Cue Biopharma Non-Current Deferred Liabilities (Quarterly) Analysis

Cue Biopharma, Inc. (CUE)

0.3437 -0.01 (-1.97%) USD | NASDAQ | Jan 14, 11:16

View Non-Current Deferred Liabilities (Quarterly) for CUE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Liabilities (Quarterly) Benchmarks

Start Trial

Insmed, Inc.	--
Puma Biotechnology, Inc.	--
Mersana Therapeutics, Inc.	Upgrade
Adaptive Biotechnologies Corp.	Upgrade
NovaBay Pharmaceuticals, Inc.	--